AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107. A total of 84 filers reported holding AVALANCHE BIOTECHNOLOGIES IN in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management, LLC | 1,382,735 | $73,076,000 | 20.10% |
Redmile Group, LLC | 699,070 | $37,750,000 | 4.11% |
Ghost Tree Capital, LLC | 125,000 | $6,750,000 | 3.24% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,614,669 | $87,192,000 | 3.13% |
Green Owl Capital Management, LLC | 26,000 | $1,404,000 | 1.26% |
COWEN INC. | 248,674 | $13,428,000 | 1.06% |
RTW INVESTMENTS, LP | 50,000 | $2,700,000 | 1.00% |
Cormorant Asset Management, LP | 65,000 | $3,510,000 | 0.54% |
Tourbillon Capital Partners, L.P. | 330,000 | $17,820,000 | 0.48% |
QVT Financial LP | 108,000 | $5,832,000 | 0.29% |